Cell proliferation following treatment with the BET bromodomain inhibitor, JQ1 (Sigma, St. Louis, MO), was assessed using the Cell Counting kit-8 (Dojindo, Japan) according to the manufacturer’s recommendation. 15,000 cells/well were plated in a 96-well plate with 1 μM of JQ1 or vehicle DMSO (Sigma, St. Louis, MO) in 100 μl of growth media. Cell viability was measured by addition of Cell Counting kit-8 reagent and luminescence measurement on a Tecan infinite M200 plate reader (Tecan, Switzerland).
Cell cycle analysis was performed 72 h after JQ1 treatment using BrdU flow kit (BD Pharmingen, San Diego, CA) according to the manufacture’s instructions. The cells were resuspended in ice cold 70% ethanol and fixed for 30 min. The cells were washed twice with PBS, then incubated for 30 min at room temperature with 0.5% RNase A and stained with 25 μg/ml propidium iodide (PI; BioLegend, San Diego, CA). Cell cycle data was obtained by using LSRII (BD Biosciences, San Diego, CA).
Apoptosis was analyzed with Annexin V and PI. Cells were incubated with Annexin V binding Buffer (BD Pharmingen, San Diego, CA), 2 μl of Annexin V-APC (BD Pharmingen, San Diego, CA) and 5 μg/ml PI. After 15 min incubation at room temperature, the cells were analyzed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.